Release Date: 04/08/22 12:43 Summary: Response to ASX Aware Letter Price Sensitive: Yes Download Document 994.78KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%